ATE513829T1 - Bicyclische arylsulfonsäureä1,3,4ü-thiadiazol-2- yl-amide, verfahren zu ihrer herstellung und ihre verwendung als pharmazeutika - Google Patents

Bicyclische arylsulfonsäureä1,3,4ü-thiadiazol-2- yl-amide, verfahren zu ihrer herstellung und ihre verwendung als pharmazeutika

Info

Publication number: ATE513829T1
Authority: AT; Austria
Prior art keywords: thiadiazole; bicyclic; pharmaceuticals; amides; production
Prior art date: 2005-10-06

Application number

AT06792248T

Other languages

English (en)

Inventor

Karl Schoenafinger

Stefanie Keil

Matthias Urmann

Hans Matter

Maike Glien

Wolfgang Wendler

Original Assignee

Sanofi Aventis

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-10-06

Filing date

2006-09-26

Publication date

2011-07-15

2006-09-26 Application filed by Sanofi Aventis filed Critical Sanofi Aventis

2011-07-15 Application granted granted Critical

2011-07-15 Publication of ATE513829T1 publication Critical patent/ATE513829T1/de

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
- C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
- C07D285/135—Nitrogen atoms

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Diabetes (AREA)
Hematology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Obesity (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pulmonology (AREA)
Emergency Medicine (AREA)
Psychology (AREA)
Endocrinology (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Child & Adolescent Psychology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AT06792248T 2005-10-06 2006-09-26 Bicyclische arylsulfonsäureä1,3,4ü-thiadiazol-2- yl-amide, verfahren zu ihrer herstellung und ihre verwendung als pharmazeutika ATE513829T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP05021785		2005-10-06
PCT/EP2006/009300 WO2007039174A2 (en)	2005-10-06	2006-09-26	Bicyclic aryl-sulfonic acid [1,3,4]-thiadiazol-2-yl-amides, processes for their preparation and their use as pharmaceuticals

Publications (1)

Publication Number	Publication Date
ATE513829T1 true ATE513829T1 (de)	2011-07-15

Family

ID=45219048

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT06792248T ATE513829T1 (de)	2005-10-06	2006-09-26	Bicyclische arylsulfonsäureä1,3,4ü-thiadiazol-2- yl-amide, verfahren zu ihrer herstellung und ihre verwendung als pharmazeutika

Country Status (19)

Country	Link
US (2)	US7612104B2 (de)
EP (1)	EP1937675B1 (de)
JP (1)	JP2009510146A (de)
KR (1)	KR20080050607A (de)
CN (1)	CN101282969A (de)
AR (1)	AR056563A1 (de)
AT (1)	ATE513829T1 (de)
AU (1)	AU2006299088A1 (de)
BR (1)	BRPI0616872A2 (de)
CA (1)	CA2624329A1 (de)
IL (1)	IL190459A0 (de)
MA (1)	MA29811B1 (de)
NO (1)	NO20081676L (de)
NZ (1)	NZ567204A (de)
RU (1)	RU2008113209A (de)
TW (1)	TW200811120A (de)
UY (1)	UY29848A1 (de)
WO (1)	WO2007039174A2 (de)
ZA (1)	ZA200801989B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW201040154A (en) *	2009-02-13	2010-11-16	Sanofi Aventis	Novel substituted indanes, process for preparation thereof and use thereof as a medicament
UY32443A (es)	2009-02-13	2010-09-30	Sanofi Aventis	Nuevos tetrahidronaftalenos, procesos para su preparación y uso de los mismos como medicamento.
GB201810092D0 (en)	2018-06-20	2018-08-08	Ctxt Pty Ltd	Compounds
GB201810581D0 (en)	2018-06-28	2018-08-15	Ctxt Pty Ltd	Compounds
SI3986890T1 (sl)	2019-06-18	2024-03-29	Ctxt Pty Ltd	Derivati benzisoksazol sulfonamida
CN116041230B (zh) *	2023-01-08	2024-03-19	中国海洋大学	一种nlrp3炎症小体抑制剂及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE1670282B2 (de) *	1967-10-24	1977-02-24		Antidiabetisch wirksame hydrindensulfonylamino-pyrimidine sowie verfahren zu deren herstellung
DE2533605A1 (de) *	1975-07-26	1977-02-03	Bayer Ag	Antiparasitenmittel
US5097669A (en) *	1991-02-11	1992-03-24	Westinghouse Electric Corp.	Control of hydrogen cooler employed in power generators
KR20020089493A (ko) *	2000-04-28	2002-11-29	상꾜 가부시키가이샤	ＰＰＡＲγ모듈레이터
AU2004255342C1 (en) *	2003-07-08	2009-05-14	Novartis Ag	Benzenesulfonylamino compounds and pharmaceutical compositions containing these compounds
US7605174B2 (en)	2005-06-09	2009-10-20	Vertex Pharmaceuticals Incorporated	Indane derivatives as modulators of ion channels

2006
- 2006-09-26 EP EP06792248A patent/EP1937675B1/de active Active
- 2006-09-26 CN CNA2006800370553A patent/CN101282969A/zh active Pending
- 2006-09-26 WO PCT/EP2006/009300 patent/WO2007039174A2/en active Application Filing
- 2006-09-26 CA CA002624329A patent/CA2624329A1/en not_active Abandoned
- 2006-09-26 AT AT06792248T patent/ATE513829T1/de not_active IP Right Cessation
- 2006-09-26 RU RU2008113209/04A patent/RU2008113209A/ru not_active Application Discontinuation
- 2006-09-26 KR KR1020087008253A patent/KR20080050607A/ko not_active Withdrawn
- 2006-09-26 AU AU2006299088A patent/AU2006299088A1/en not_active Abandoned
- 2006-09-26 JP JP2008533906A patent/JP2009510146A/ja not_active Abandoned
- 2006-09-26 BR BRPI0616872-8A patent/BRPI0616872A2/pt not_active IP Right Cessation
- 2006-09-26 NZ NZ567204A patent/NZ567204A/en not_active IP Right Cessation
- 2006-09-27 TW TW095135655A patent/TW200811120A/zh unknown
- 2006-10-04 AR ARP060104362A patent/AR056563A1/es not_active Application Discontinuation
- 2006-10-06 UY UY29848A patent/UY29848A1/es not_active Application Discontinuation
2008
- 2008-03-03 ZA ZA200801989A patent/ZA200801989B/xx unknown
- 2008-03-26 IL IL190459A patent/IL190459A0/en unknown
- 2008-03-31 MA MA30789A patent/MA29811B1/fr unknown
- 2008-04-04 NO NO20081676A patent/NO20081676L/no not_active Application Discontinuation
- 2008-04-04 US US12/062,759 patent/US7612104B2/en not_active Expired - Fee Related
2009
- 2009-09-24 US US12/566,179 patent/US7772257B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
IL190459A0 (en)	2008-11-03
BRPI0616872A2 (pt)	2011-07-05
EP1937675B1 (de)	2011-06-22
NO20081676L (no)	2008-04-29
US20080293780A1 (en)	2008-11-27
NZ567204A (en)	2010-06-25
CN101282969A (zh)	2008-10-08
MA29811B1 (fr)	2008-09-01
US20100022603A1 (en)	2010-01-28
UY29848A1 (es)	2007-05-31
US7612104B2 (en)	2009-11-03
US7772257B2 (en)	2010-08-10
WO2007039174A3 (en)	2007-08-09
JP2009510146A (ja)	2009-03-12
AR056563A1 (es)	2007-10-10
RU2008113209A (ru)	2009-10-10
TW200811120A (en)	2008-03-01
AU2006299088A1 (en)	2007-04-12
WO2007039174A2 (en)	2007-04-12
ZA200801989B (en)	2009-08-26
CA2624329A1 (en)	2007-04-12
KR20080050607A (ko)	2008-06-09
EP1937675A2 (de)	2008-07-02

Publication	Publication Date	Title
DE502005009723D1 (de)	2010-07-22	Arylsubstituierte heterozyklen, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE502004011957D1 (de)	2011-01-13	Neue cyanopyrrolidide, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE602007010640D1 (de)	2010-12-30	Pyrazolopyrimidine, ein verfahren zu ihrer herstellung und ihre verwendung als medizin
DE502005007840D1 (de)	2009-09-17	7-phenylamino-4-chinolon-3-carbonsäure-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
ATE348609T1 (de)	2007-01-15	Tetrahydronaphthalinderivate, verfahren zu ihrer herstellung und ihre verwendung als entzündungshemmer
ATE381564T1 (de)	2008-01-15	Arylsubstituierte polycyclische amine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
EP1906468A4 (de)	2009-11-11	Batteriedose und verfahren zu ihrer herstellung
ATE441638T1 (de)	2009-09-15	4,5-diphenyl-pyrimidinyl substituierte carbonsäuren, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
EP1894626A4 (de)	2012-10-10	Homogener, hochdisperser metallkatalysator und verfahren zu seiner herstellung
ATE554772T1 (de)	2012-05-15	Pteridine als hcv-hemmer und verfahren zu ihrer herstellung
DE502005010912D1 (de)	2011-03-10	Dihydropteridinonderivate, verfahren zu deren herstellung und deren verwendung als arzneimittel
ATE433976T1 (de)	2009-07-15	Substituierte pyrrolopyridine, zusammensetzungen damit und verfahren zu ihrer herstellung und verwendung
DE602006007336D1 (de)	2009-07-30	Umspritzte behälter und verfahren zu deren herstellung
DE602006012666D1 (de)	2010-04-15	Ren eignen und verfahren zu deren herstellung
DE602006013001D1 (de)	2010-04-29	Zusammensetzung mit verbesserter stabilität und verfahren zu ihrer herstellung
ATE471325T1 (de)	2010-07-15	Imidazoä1,2-büpyridazine, verfahren zu ihrer herstellung und ihre verwendung als gaba-rezeptor-liganden
ATE496041T1 (de)	2011-02-15	2,6-chinolinderivate sowie verfahren zu ihrer herstellung und verwendung als arzneimittel
DE50207011D1 (de)	2006-07-06	Arylisoxazolin-derivative, verfahren zu ihrer herstellung und ihre verwendung als schädlingsbekämpfungsmittel
ATE535510T1 (de)	2011-12-15	Benzylamine, verfahren zu ihrer herstellung und ihre verwendung als entzündungshemmende mittel
DE502006009351D1 (de)	2011-06-01	Feinteiliges azopigment und verfahren zu seiner herstellung
ATE517092T1 (de)	2011-08-15	Tetrahydronaphthalinderivate, verfahren zu ihrer herstellung und ihre verwendung als entzündungshemmer
ATE473738T1 (de)	2010-07-15	1-sulfonylindolderivate, verfahren zu ihrer herstellung und ihre verwendung als 5-ht6 liganden
ATE496046T1 (de)	2011-02-15	Arylvinylazacycloalkan-verbindungen und verfahren zu deren herstellung und verwendung
DE602005026059D1 (de)	2011-03-03	Solarbatteriezelle und verfahren zu ihrer herstellung
DE502004005578D1 (de)	2008-01-03	Hochtackige klebmasse, verfahren zu deren herstellung und deren verwendung

Legal Events

Date	Code	Title	Description
2011-12-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties